img

Global Peyronie’s Disease Treatment Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Peyronie’s Disease Treatment Market Research Report 2024

Peyronie's disease (PD) is condition wherein the penis is curved or bent due to development of plaque or a fibrous scar tissue inside the penis. 
According to MRAResearch’s new survey, global Peyronie’s Disease Treatment market is projected to reach US$ 838.2 million in 2033, increasing from US$ 425 million in 2022, with the CAGR of 10.2% during the period of 2023 to 2033. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Peyronie’s Disease Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Peyronie’s Disease Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Endo International
Asahi Kasei
BioSpecifics Technologies
Segment by Type
Drugs
Surgery

Segment by Application


Hospital
Drugs Store
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Peyronie’s Disease Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peyronie’s Disease Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Drugs
1.2.3 Surgery
1.3 Market by Application
1.3.1 Global Peyronie’s Disease Treatment Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peyronie’s Disease Treatment Market Perspective (2018-2033)
2.2 Peyronie’s Disease Treatment Growth Trends by Region
2.2.1 Global Peyronie’s Disease Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Peyronie’s Disease Treatment Historic Market Size by Region (2018-2023)
2.2.3 Peyronie’s Disease Treatment Forecasted Market Size by Region (2024-2033)
2.3 Peyronie’s Disease Treatment Market Dynamics
2.3.1 Peyronie’s Disease Treatment Industry Trends
2.3.2 Peyronie’s Disease Treatment Market Drivers
2.3.3 Peyronie’s Disease Treatment Market Challenges
2.3.4 Peyronie’s Disease Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peyronie’s Disease Treatment Players by Revenue
3.1.1 Global Top Peyronie’s Disease Treatment Players by Revenue (2018-2023)
3.1.2 Global Peyronie’s Disease Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Peyronie’s Disease Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Peyronie’s Disease Treatment Revenue
3.4 Global Peyronie’s Disease Treatment Market Concentration Ratio
3.4.1 Global Peyronie’s Disease Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peyronie’s Disease Treatment Revenue in 2022
3.5 Peyronie’s Disease Treatment Key Players Head office and Area Served
3.6 Key Players Peyronie’s Disease Treatment Product Solution and Service
3.7 Date of Enter into Peyronie’s Disease Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Peyronie’s Disease Treatment Breakdown Data by Type
4.1 Global Peyronie’s Disease Treatment Historic Market Size by Type (2018-2023)
4.2 Global Peyronie’s Disease Treatment Forecasted Market Size by Type (2024-2033)
5 Peyronie’s Disease Treatment Breakdown Data by Application
5.1 Global Peyronie’s Disease Treatment Historic Market Size by Application (2018-2023)
5.2 Global Peyronie’s Disease Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Peyronie’s Disease Treatment Market Size (2018-2033)
6.2 North America Peyronie’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Peyronie’s Disease Treatment Market Size by Country (2018-2023)
6.4 North America Peyronie’s Disease Treatment Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peyronie’s Disease Treatment Market Size (2018-2033)
7.2 Europe Peyronie’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Peyronie’s Disease Treatment Market Size by Country (2018-2023)
7.4 Europe Peyronie’s Disease Treatment Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peyronie’s Disease Treatment Market Size (2018-2033)
8.2 Asia-Pacific Peyronie’s Disease Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Peyronie’s Disease Treatment Market Size by Region (2018-2023)
8.4 Asia-Pacific Peyronie’s Disease Treatment Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peyronie’s Disease Treatment Market Size (2018-2033)
9.2 Latin America Peyronie’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Peyronie’s Disease Treatment Market Size by Country (2018-2023)
9.4 Latin America Peyronie’s Disease Treatment Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peyronie’s Disease Treatment Market Size (2018-2033)
10.2 Middle East & Africa Peyronie’s Disease Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Peyronie’s Disease Treatment Market Size by Country (2018-2023)
10.4 Middle East & Africa Peyronie’s Disease Treatment Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Endo International
11.1.1 Endo International Company Detail
11.1.2 Endo International Business Overview
11.1.3 Endo International Peyronie’s Disease Treatment Introduction
11.1.4 Endo International Revenue in Peyronie’s Disease Treatment Business (2018-2023)
11.1.5 Endo International Recent Development
11.2 Asahi Kasei
11.2.1 Asahi Kasei Company Detail
11.2.2 Asahi Kasei Business Overview
11.2.3 Asahi Kasei Peyronie’s Disease Treatment Introduction
11.2.4 Asahi Kasei Revenue in Peyronie’s Disease Treatment Business (2018-2023)
11.2.5 Asahi Kasei Recent Development
11.3 BioSpecifics Technologies
11.3.1 BioSpecifics Technologies Company Detail
11.3.2 BioSpecifics Technologies Business Overview
11.3.3 BioSpecifics Technologies Peyronie’s Disease Treatment Introduction
11.3.4 BioSpecifics Technologies Revenue in Peyronie’s Disease Treatment Business (2018-2023)
11.3.5 BioSpecifics Technologies Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Peyronie’s Disease Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Drugs
Table 3. Key Players of Surgery
Table 4. Global Peyronie’s Disease Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 5. Global Peyronie’s Disease Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global Peyronie’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Peyronie’s Disease Treatment Market Share by Region (2018-2023)
Table 8. Global Peyronie’s Disease Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global Peyronie’s Disease Treatment Market Share by Region (2024-2033)
Table 10. Peyronie’s Disease Treatment Market Trends
Table 11. Peyronie’s Disease Treatment Market Drivers
Table 12. Peyronie’s Disease Treatment Market Challenges
Table 13. Peyronie’s Disease Treatment Market Restraints
Table 14. Global Peyronie’s Disease Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Peyronie’s Disease Treatment Market Share by Players (2018-2023)
Table 16. Global Top Peyronie’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peyronie’s Disease Treatment as of 2022)
Table 17. Ranking of Global Top Peyronie’s Disease Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Peyronie’s Disease Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Peyronie’s Disease Treatment Product Solution and Service
Table 21. Date of Enter into Peyronie’s Disease Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Peyronie’s Disease Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Peyronie’s Disease Treatment Revenue Market Share by Type (2018-2023)
Table 25. Global Peyronie’s Disease Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global Peyronie’s Disease Treatment Revenue Market Share by Type (2024-2033)
Table 27. Global Peyronie’s Disease Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Peyronie’s Disease Treatment Revenue Market Share by Application (2018-2023)
Table 29. Global Peyronie’s Disease Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global Peyronie’s Disease Treatment Revenue Market Share by Application (2024-2033)
Table 31. North America Peyronie’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 32. North America Peyronie’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Peyronie’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 34. Europe Peyronie’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. Europe Peyronie’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Peyronie’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 37. Asia-Pacific Peyronie’s Disease Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 38. Asia-Pacific Peyronie’s Disease Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Peyronie’s Disease Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 40. Latin America Peyronie’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 41. Latin America Peyronie’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Peyronie’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 43. Middle East & Africa Peyronie’s Disease Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Middle East & Africa Peyronie’s Disease Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Peyronie’s Disease Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 46. Endo International Company Detail
Table 47. Endo International Business Overview
Table 48. Endo International Peyronie’s Disease Treatment Product
Table 49. Endo International Revenue in Peyronie’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 50. Endo International Recent Development
Table 51. Asahi Kasei Company Detail
Table 52. Asahi Kasei Business Overview
Table 53. Asahi Kasei Peyronie’s Disease Treatment Product
Table 54. Asahi Kasei Revenue in Peyronie’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 55. Asahi Kasei Recent Development
Table 56. BioSpecifics Technologies Company Detail
Table 57. BioSpecifics Technologies Business Overview
Table 58. BioSpecifics Technologies Peyronie’s Disease Treatment Product
Table 59. BioSpecifics Technologies Revenue in Peyronie’s Disease Treatment Business (2018-2023) & (US$ Million)
Table 60. BioSpecifics Technologies Recent Development
Table 61. Research Programs/Design for This Report
Table 62. Key Data Information from Secondary Sources
Table 63. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Peyronie’s Disease Treatment Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Peyronie’s Disease Treatment Market Share by Type: 2022 VS 2033
Figure 3. Drugs Features
Figure 4. Surgery Features
Figure 5. Global Peyronie’s Disease Treatment Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 6. Global Peyronie’s Disease Treatment Market Share by Application: 2022 VS 2033
Figure 7. Hospital Case Studies
Figure 8. Drugs Store Case Studies
Figure 9. Peyronie’s Disease Treatment Report Years Considered
Figure 10. Global Peyronie’s Disease Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 11. Global Peyronie’s Disease Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 12. Global Peyronie’s Disease Treatment Market Share by Region: 2022 VS 2033
Figure 13. Global Peyronie’s Disease Treatment Market Share by Players in 2022
Figure 14. Global Top Peyronie’s Disease Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peyronie’s Disease Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Peyronie’s Disease Treatment Revenue in 2022
Figure 16. North America Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 17. North America Peyronie’s Disease Treatment Market Share by Country (2018-2033)
Figure 18. United States Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. Canada Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. Europe Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. Europe Peyronie’s Disease Treatment Market Share by Country (2018-2033)
Figure 22. Germany Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. France Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. U.K. Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Italy Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Russia Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Nordic Countries Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Asia-Pacific Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Asia-Pacific Peyronie’s Disease Treatment Market Share by Region (2018-2033)
Figure 30. China Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Japan Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. South Korea Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Southeast Asia Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. India Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Australia Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Latin America Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Latin America Peyronie’s Disease Treatment Market Share by Country (2018-2033)
Figure 38. Mexico Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Brazil Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Middle East & Africa Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Middle East & Africa Peyronie’s Disease Treatment Market Share by Country (2018-2033)
Figure 42. Turkey Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Saudi Arabia Peyronie’s Disease Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Endo International Revenue Growth Rate in Peyronie’s Disease Treatment Business (2018-2023)
Figure 45. Asahi Kasei Revenue Growth Rate in Peyronie’s Disease Treatment Business (2018-2023)
Figure 46. BioSpecifics Technologies Revenue Growth Rate in Peyronie’s Disease Treatment Business (2018-2023)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed